Stroma-Infiltrating T Cell Spatiotypes Define Immunotherapy Outcomes in Adolescent and Young Adult Patients with Melanoma

The authors characterized the immunogenomic profile and spatial architecture of the tumor microenvironment in adolescent and young adult (AYA) and older adult patients with melanoma, to determine the AYA-specific features associated with immune checkpoint inhibitors treatment outcomes.